Caldan Therapeutics Limited

LSH are seeking offers for the business assets of Caldan Therapeutics Limited, including the intellectual property and associated assets, together with compound stocks, related to many years of cutting-edge research into the pharmaceutical treatment of diabetes and associated conditions.

The offer deadline is 11 October.

Further details here.